Levine Cancer Institute — Charlotte, North Carolina

Public research footprint of Levine Cancer Institute, compiled from the ClinicalTrials.gov public registry.

674

Registered studies

325

Active

143

Recruiting now

272

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Castration-Resistant Prostate Cancer (CRPC) · Breast Cancer

Recently updated registry entries

NCT05554406 — Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed… (Recruiting)
NCT03698019 — A Study to Compare the Administration of Pembrolizumab After Surgery Versus… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Levine Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.